跳至主要内容
临床试验/NCT02411383
NCT02411383已完成不适用

Prospective, Single-centre, Open-label Clinical Study to Investigate the Safety and Performance of the NeuRx Diaphragm Pacing System (DPS) in Patients Undergoing Bilateral Lung Transplantation

Synapse Biomedical1 个研究点 分布在 1 个国家目标入组 4 人开始时间: 2015年2月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
4
试验地点
1
主要终点
Tolerability: Patient withdrawal from treatment.

研究概览

简要总结

This study is a prospective, single-center feasibility study to acquire more knowledge regarding the NeuRx DPS and develop a routine in the optimal pacing of the diaphragm with this system during the weaning period from mechanical ventilation in the Intensive Care Unit in patients after bilateral lung transplant.

详细描述

This study is a prospective, single-center feasibility study to acquire more knowledge regarding the NeuRx DPS and develop a routine in the optimal pacing of the diaphragm with this system during the weaning period from mechanical ventilation in the Intensive Care Unit in patients after bilateral lung transplant. The objectives are to evaluate the safety and technical performance of DPS by assessing:

  • the immediate safety and technical surgical results of implantation
  • the safety and tolerability of use and removal until patient discharge from the Intensive Care Unit (ICU) or hospital
  • the effects of diaphragm pacing on MV interaction, diaphragm force, fatigue resistance, and diaphragm electromyography (EMG)

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

性别
All
接受健康志愿者

入选标准

  • Patient is undergoing bilateral lung transplantation
  • Signed written informed consent has been obtained prior to any study related procedure

排除标准

  • Diaphragm malformation which makes the electrode insertion impossible
  • Presence of contra-indications for magnetical stimulation; pacemaker or implantable cardioverter-defibrillator, prosthetic valve, cervical implants, cervical trauma
  • Participation in other clinical studies that could interfere with the results in the ongoing study

结局指标

主要结局

Tolerability: Patient withdrawal from treatment.

时间窗: 30 days

Safety: Daily assessment of device or procedure-related adverse events until patient discharge.

时间窗: 30 days

Pacing success: Ability to ventilate the patient through diaphragm pacing with or without assistance of mechanical ventilation.

时间窗: 30 days

次要结局

  • Composite endpoint(30 days)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验